Federal Supply Schedule V797D50459
- Sebela Pharmaceuticals Inc. was awarded a multiple-award Federal Supply Schedule contract under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB) effective April 1, 2024, with an ultimate completion date of March 31, 2029. This civilian contract, funded by the Veterans Integrated Service Network 12, carries a ceiling value of $57,999,080 and represents a five-year indefinite delivery vehicle with no set-aside provisions. The contract authorizes the delivery...
- The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
- This Federal Supply Schedule award was granted to AmerisourceHealth Services LLC, a child entity operating under the Amerisource Health Packaging division, to supply pharmaceuticals, drugs, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract was awarded on September 15, 2023, under the General Services Administration's Pharmaceuticals and Drugs schedule (FSS-61-IB), with a ceiling value...
- This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
- The Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Nextgen Pharmaceuticals LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. With a potential value of $400,000 and a period of performance through July 2028, the multiple award contract aims to meet the healthcare needs of veterans through the procurement of pharmaceuticals and...
- The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
- The subject contract is a Federal Supply Schedule (FSS) award to Pharmaceutical Specialties Inc. by the Veterans Integrated Service Network 12, a civilian agency. The FSS contract is under Schedule 65-IB, covering Drugs, Pharmaceuticals, and Hematology Related Products. The contract has a ceiling value of $11,713,300.00 and a period of performance through November 30, 2026. The purpose of this FSS contract is to provide the procuring agency with access to a broad range of pharmaceutical and drug...
- The Federal Supply Schedule contract is a multiple award vehicle awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to Validus Pharmaceuticals, LLC. The contract has a period of performance from April 1, 2023 to March 31, 2028 and a ceiling value of $2,420,310.00. The contract is for pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The agency aims to procure a wide range of pharmaceutical and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
- Valinor Pharma, LLC has been awarded a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule to provide drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. This multiple-award indefinite delivery vehicle carries a ceiling value of $225,000 and was awarded on October 15, 2023, with an ultimate completion date of October 14, 2028,...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D50459Federal Supply Schedule
- Blanket Purchase Agreements
This Federal Supply Schedule contract provides pharmaceuticals and related products to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. Awarded on August 15, 2016 to Sebela Pharmaceuticals Inc., it has a potential value of $25.57 million through its period of performance ending March 31, 2024. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule master schedule, identified as FSS-61-IB. It facilitates delivery of products categorized under Schedule 65IB, which includes drugs, pharmaceuticals, and hematology-related items. No set-aside provisions were applied. As a multiple-award contract, it permits ordering from an established price list by Network 12 locations to meet their pharmaceutical procurement needs over the eight-year period. The contract aims to support Veterans Health Administration medical facilities in efficiently obtaining necessary pharmaceuticals and related products. By establishing firm pricing through this Indefinite Delivery Vehicle, the network can more easily fulfill its mission of providing quality healthcare to veterans through this streamlined acquisition process for essential medical supplies. The prime contractor, Sebela Pharmaceuticals, is a for-profit manufacturer positioned to provide the contracted products over the remaining term.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00053 | Supplemental Agreement for work within scope | $0 | 1/31/24 | |
| P00052 | Supplemental Agreement for work within scope | $0 | 10/28/23 | |
| P00051 | Supplemental Agreement for work within scope | $0 | 9/28/23 | |
| P00050 | Supplemental Agreement for work within scope | $0 | 9/27/23 | |
| P00049 | Supplemental Agreement for work within scope | $0 | 7/12/23 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Roxane Laboratories, Inc. 900 Ridgebury Road Ridgefield, CT 06877 | 65IB | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 8/12/16, 2:39 PM |